Abstract
Expert guidelines and the “Choosing Wisely” initiative recommend single fraction radiation therapy (RT) as the preferred treatment for painful bone metastases because it achieves comparable pain relief, is more convenient, and is less costly than multiple fraction treatment. In 2011, ASTRO published clinical guidelines supporting single fraction RT as an appropriate treatment for uncomplicated painful bone metastases. We report findings from a cohort of commercially insured patients with six prevalent cancers treated before and after the ASTRO guidelines were published.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
